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Simultaneous analysis of morbidity and mortality factors in chronic
hemodialysis patients. The Cox stepwise logistic regression model was
applied to analyze 22 factors potentially affecting morbidity and mor-
tality (MM) in a cohort of 104 patients on chronic hemodialysis (CHD).
Two groups of predictor variables were considered: patients' charac-
teristics at the start of the study, and treatment-related factors recorded
throughout the observation period. End points were either failure
(death or admission to a hospital) or success. Patients were followed for
24 months. Thirty-nine patients were hospitalized and seven died in the
interval. The two leading causes of failure were cardiovascular and
infectious complications. Variables significantly associated with the
result were: cardiac status (score > 2, /3 = 1.16), mean predialysis blood
pressure (> 115 mm Hg, /3 = 0.94), total dialysis dose (>0.90,
p =
—0.59) and age (> 55 years, /3 0.51). The probability of failure
was 0.13 for patients who presented the four variables in the lowest risk
class. This increased to a maximum of 0.60 with one risk factor, to 0.91
with two risk factors, and to 0.99 with three or more risk factors. We
conclude that, given the conditions for this study, two treatment-related
variables of CHD (mean predialysis blood pressure and total dialysis
dose) are MM factors even when simultaneously analyzed with other
well-established predictors (cardiac status and age). Mean arterial
pressure (MAP) is the most important CHD treatment-related MM
predictor.
It has been pointed out that morbidity and mortality (MM) are
higher in patients who are on chronic hemodialysis (CHD)
therapy than in the overall population [1]. This has been
associated with several factors: demographic characteristics,
former and persistent diseases co-existing with chronic renal
failure (CRF), socio-economic status and psychological factors,
as well as CHD treatment quality [1—7]. Most studies present an
analysis of some of these aspects.
The purpose of this prospective study is to carry out a
simultaneous analysis of the variables potentially affecting MM
at any time during the CHD patient's evolution, to identify
predictors, and to evaluate their relative weight on the out-
come. The Cox stepwise logistic regression model [8] was used
to correlate 22 independent variables with the result defined as
treatment success or failure. Failure was admission of the
patient in the hospital or death.
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Methods
Patients
The study was performed at two dialysis units in Montevideo,
Uruguay, from January 1, 1987 to June 30, 1990. The patients
were transferred to these units by a National Committee
(National Fund Resource), and were selected at random. Dur-
ing this period, 186 patients were on dialysis; of these, 104
fulfilled the criteria to be included in this study.
Table 1 shows demographic aspects. The patients received
the routine treatment given at the participating units. The aims
were: to maintain the patients free of symptoms and rehabili-
tated; predialysis BUN below 80 mg!dl; normalized total dialy-
sis dose (KT/V01) > 0.80; normalized protein catabolic rate
(PCR) between 1 and 1.4 glkg!day; predialysis MAP < 110 mm
Hg; calcemia between 9 and 11 mg%, phosphorus < 6 mg%,
and potassium < 5.8 mEqlliter. Failure to reach these goals was
either due to the patient's non-compliance with directions or to
unintentional mistakes in the treatment schedule. Hemodialysis
water was demineralized, keeping conductivity below 50 tS/
cm. Cuprophane hollow fiber hemodialyzers measuring 1.1 to
1.25 sqm, and 8 to 12 micron thickness were used. Cellulose
acetate membrane hemodialyzers were temporarily used on six
patients. Mean re-use was seven times. Patients underwent
hemodialysis for 9 to 15 hours weekly, in three sessions. The
standard dialysate composition was: Na, 140 mEq/liter; K, 2.5
mEqlliter; Ca, 3.5 mEq/liter; acetate, 35 mEq/liter. Bicarbonate
was used on patients prone to hypotensive events. Dialysate
potassium was 3.5 mEq/liter for digitalized patients and glucose
was 2 g/liter for diabetic and some elderly patients.
Diet was prescribed according to the following criteria: 35 to
45 Kcallkg, 1 to 1.2 g/kg/day of proteins, variable restriction of
Na, K and fluids according to clinical status.
The patients received B 12 and C vitamin, folic acid, iron, and
calcium supplements. Most of them received CaCO3 or
Al(OH)3 as the phosphate binder. Depending on bone disease
diagnosis, some received 1 .25(OH)2D3. Anti-hypertensive
drugs were prescribed when blood pressure control could not
be achieved by hemodialysis alone (36% of patients). Drugs
used were: enalapril, clonidine, Ca channel blockers and beta
blockers. All patients were submitted to a complete check-up at
the start of dialysis, and more than once a year thereafter
according to clinical status.
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Number of patients
Sex
Female
Male
Age
Primary renal diagnosis
Chronic glomerulonephritis
Chronic interstitial
Nephritis
Polycystic kidney disease
Hypertension
Diabetes
Lupus nephritis
Unknown
Time in dialysis
Private medical care coverage
Values are mean SD.
Pre- and post-dialysis MAP and weight, dialysis time and
technical characteristics of HD sessions were recorded.
Monthly tests included BUN concentration prior to and after
one dialysis and prior to the next subsequent treatment, predi-
alysis K, Ca, P, hematocrit (Hct) and alkaline phosphatase.
Annual assessment included at least chest and bone X-ray,
ECG, ocular fundus, leukocyte count, proteinemia, liver func-
tion tests, glycemia, and residual urea clearance.
Methods
Each patient was followed either during two full years or until
failure, whichever occurred first.
During the first five months of observation (preliminary
phase) only predictor variables were recorded, and from then
on (observation phase) failures were recorded as well. Patients
who did not complete the preliminary phase, or those admitted
to the dialysis units after June 30, 1988 were not included in the
study. Also, we did not include transplanted patients or those
transferred to other centers before achieving follow-up.
Both units had a central computerized data base containing
the following information about each patient; demographic
characteristics, clinical history on admission to CHD, family
socio-economic status, and psychological evaluation, records
of each HD session, nutritional assessment, monthly and an-
nual tests, complications and hospital admissions. Variables of
the analysis were:
1. Independent variables or predictors. These were classified
as:
a. Variables describing the patient status when he/she was
included in the cohort. Demographic characteristics, smoking
habit, alcoholism. History of chronic pleuropulmonary disorder
(CPD): chronic obstructive pulmonary disease, asthma, TBC.
Hypertension history (HH) during six months or more prior to
the observation period; HH was considered severe when the
diastolic pressure persisted over 100 mm Hg in most readings in
spite of treatment. The cardiac status (CS) was scored 0 to 8
according to the following data: personal history of myocardial
infarction (absent: 0, present: 2), cardiac insufficiency (absent:
0, compensated: 2, decompensated: 3), manifestations of myo-
cardial ischemia: (absent: 0, electrocardiographic only: 2, an-
gina pectoris; 3). The patients were divided into two groups
according to these scores: 0 to 2 (class 1) and over 2 (class 2),
Smokers 40 (38.5%)
Alcoholics 23 (22.1%)
Chronic pulmonary diseases 15 (14.4%)
Hypertensive history
Mild 32 (30.8)
Severe 16 (15.4%)
Table 3. Patient distribution according to cardiac score
Class Cardiac score Number of patients
1 0 48
1 1 77.9%
2 32
2 3 7
4 5
5 7 22.1%
7 3
8 1
Nutritional assessment was performed using the following
anthropometric measurements: tricipital and subscapular skin-
fold addition (TSSA) and arm muscular area (AMA). Data were
compared with that of a healthy population in Uruguay [91 and
expressed in percentiles. Socioeconomic status (SES) was
established using the Gardara Graciano criteria [101 adapted to
our country: family income per capita, housing, occupation and
educational status of the head of the family. Each item scored 0
to 5 points. Five groups were established according to these
scores: 1) 5 or less; indigence; 2) 6 to 9: poverty; 3)10 to 13:
basic needs covered; 4)14 to 17: living with some comfort; 5)
more than 17: reach comfort levels without difficulty. Family
support (FAMS) was classified in four distinct groups, as
follows: 1) conflictive family relationship or abandonment; 2)
dependence, overprotection, no integration to social groups; 3)
slightly conflictive family relationships, little participation of
family; 4) no apparent family conflict, suitable family participa-
tion.
Psychological (PS) assessment was established considering
presence and intensity of clinical psychic signs; presence of
signs was determined based on: psychological diagnosis accord-
ing to lCD IX [1 1], need for psychotropic drugs, or repeated
psychiatric consultations. Four groups were classified accord-
ingly; 1) no signs, 2) mild, 3) moderate, and 4) severe signs.
Tables 2 to 4 show patient distribution according to these
discrete independent variables.
b. Treatment-related variables. These were recorded through-
out the observation period: predialysis MAP, monthly predial-
ysis Hct, K, BUN, time-averaged BUN concentration (TAC),
KT/V0 and PCR. The statistical analysis was made on the
average of the records for each patient. For MAP, N (number of
observations) was the number of HD sessions during the
observation period; for the other variables, it was the number of
months of the observation period. No average was calculated
with less than five data.
Urea kinetics data were computed using the single compart-
ment model with the variable volume equations [12, 13]. The
dialyzers' clearances of the manufacturers were not used be-
cause, according to our and other authors' experience [14],
Table 1. Demographic variables TaMe 2. Associated factors
104
39 (37.5%)
65 (62.5%)
55.5 15 years
32 (30.8%)
17 (16.3%)
10 (9.6%)
14 (13.5%)
8 (7.7%)
2 (1.9%)
23(22.1%)
45.4 26.5 months
63 (60.6%)
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Table 4. Patient distribution according to socio-economic (SES),
familiar support (FAMS), psychological (PS) score and
anthropometric measurements at the start of the study
Class
SES FAMS PS
N
1 8 3 18
2 49 3 27
3 17 31 15
4 16 63 33
5 6 — —
(No data available) 8 4 11
TSSA percentile 45.2 36.7 (1 SD)
AMA percentile 30.2 27.2( SD)
Table 5. Continuous variables recorded during the study
Number of
patients Mean SD
Hematocrit 104 24.9 4.0
Potassium mEqiliter 104 5.3 0.3
BUN mg/dl 104 76.8 10.9
TACorea mg/dl 104 54.4 8.2
PCR g/kg/day 104 1.02 0.21
KT/V , 104 0.99 0.13
MAP mm Hg 104 106.6 9.5
Abbreviations are: TACorea, time average BUN concentration; PCR,
protein catabolic rate normalized to postdialysis body weight; KT/VO,
total dialysis dose; MAP, predialysis mean arterial pressure.
their values are over effective clearance; this was proved in
both reused and new dialyzers. The effective clearance was
calculated by repeatedly applying the above equations. Body
water volume was estimated using Hume's equation [15].
KT/V0 was calculated by applying the equation proposed by
Teschan [16]. The average number of kinetic studies was 15
(range 5 to 24) per patient.
Mean values for these continuous variables are shown in
Table 5. The dependent variable was the result of treatment:
either failure (admission to the hospital or death) or success.
Admission to the hospital due to elective surgery or AVF
noninfectious complications were not considered.
Forty-six patients failed during the study: 7 died and 39 were
hospitalized. Table 6 shows the detail of the causes of death and
hospital admission. Table 7 shows distribution of failure during
the observation period.
Statistical analysis
The stepwise logistic regression model proposed by Cox [81
was used. This model permits a correlation between a dichot-
omous dependent variable (result) with a set of continuous or
discrete independent variables (predictors).
The equation of the model is:
Ln(F/1—F)=/3o+f3lXli+...+/3kXki
Table 6. Causes of death and hospitalization
Number of patients
Hospitalization Death
Cardiovascular 26 (56.5%)a
Angina pectoris 5 —
Arrhythmia 4 1
Hypervolemia 6 —
Cerebrovascular accident 2 2
Severe hypertension 2 —
Pulmonary embolism — I
Peripheral vascular disease 3 —
Infectious 15 (32.6%)a
Tbc I —
Pneumonia 5 —
Sepsis 3 2
Vascular access infection I —
Intestinal infection I —
Parietal abscess I —
Febrile syndrome 1 —
Others 5 (lO.9%)a
Gastrointestinal bleeding 2 —
Postoperative complication I —
Brain cancer — I
Psychosis I —
a % over total of failures
Table 7. Distribution of failures during the observation period
Months 0 5 10 15 20 24
Patients
on the study 104 104 89 75 62 58
Failures 15 14 13 4
where F is the probability of failure, (Xli, .
. ., Xki) the vector
of predictors of the ith patient and (f3o, /31, .
. ., /3k) the vector
of regression coefficients to be estimated.
Selection of the best predictors of treatment failure and
establishment of the relative importance of each one in predict-
ing failure are both allowed by this model.
The software used for analyzing data was a 1987 version of
LRP BMDP, which estimates the regression coefficients by the
maximum likelihood method, and proceeds in a stepwise fash-
ion.
In the first stage, the independent variables were analyzed
separately. The continuous variables were analyzed as such and
also divided into two classes. Only those variables significantly
associated with the results in the first stage were included in the
simultaneous analysis (second stage). Among them, the contin-
uous variables were used considering the cutpoint with maximal
significance. Once the group of significant variables was iden-
tified, the analysis was repeated with different variable combi-
nations.
Variables were considered to be significant when they im-
proved the likelihood equation with P < 0.05, accepting the
estimated coefficient /3 when /3/sE  2.
Results
The variables that were significant in the first analysis were
(1) CS (class 1: 2, class 2: >2), MAP(class 1: 1l5 mm Hg, class
a,
S
a
0
.0
.00I.-0
0.6
0.5
0.4
0.3
0.2
0.1
0Age >55 years
KTN (tot) O.90
MAP >115mm Hg
GS2
- + -
— - +
+
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Table 8. Number of patients and failures in low and high risk class
of the significant variables
Significant
Low risk class High risk class
Number of Number of Number of Number of
variables patients failures patients failures
CS 81 27 23 19
MAP 87 33 17 13
KT/V0 77 29 27 17
Age 45 17 59 29
Abbreviations are: CS, cardiac score; MAP, predialysis mean arterial
pressure; KT/V,,, total dialysis dose.
Table 9. Parameters estimated by stepwise logistic regression
method
Coefficient
Class 2 (f3) 5EM f3/5EM F P
CS >2 1.16 0.32 3.62 13.0 0.0005
MAP >115 0.94 0.35 2.70 7.3 0.008
KT/V,, >0.9 —0.59 0.27 —2.18 4.7 0.032
Age >55 0.51 0.25 2.03 4.1 0.046
Constant (Bo) 1.29 0.44
Abbreviations are: CS, cardiac score; MAP, predialysis mean arterial
pressure; KT/V,01, total dialysis dose; F, statistic F to remove.
2: >115), KT/VO (class 1: 0.90, class 2: > 0.90) and HH
(class 1: absence of or mild HH, class 2: severe HH).
When the second analysis was performed, the group of
significant variables was CS, MAP and KT/V0.
The simultaneous analysis was repeated six times, including
both the three significant variables and groups of interrelated
variables: socio-economic (SES, FAMS, PS, medical care),
demographic (sex, age, renal disease, time on hemodialysis),
urea kinetics (PCR, BUN and TACurea), nutritional assessment
(PCR, TSSA and AMA), associated factors (alcoholism, smok-
ing, CPD) and others (Hct, K). Three mentioned variables (CS,
MAP, KT/V0) and age were significant.
Table 8 shows the number of patients and failures in each
variable class in the second analysis. Table 9 presents the
results of the regression. The coefficients correspond to class 2.
Class 1 coefficients can be obtained by multiplying the former
by — 1. The strongest predictor was CS since its coefficient
presented the highest absolute value. In decreasing order the
following were MAP, KT/YIQ and age. A direct relationship
between CS, MAP, age and F was found, whereas it was
inverse between KT/VO and F.
F was estimated applying the regression equation 1. Figure 1
shows the plotting of F values according to significant variables
taken separately. The shaded area in each bar indicates the risk
attributed (RA) to MAP or KT/V0 (RA = P1 — P2, where P1
risk of exposed patients and P2 risk of unexposed patients,
with relation to a defined factor). When the values of the four
predicting variables were in the lowest-risk class (CS, class 1;
MAP, class 1; KTIV,0, class 2 and age, class 1) the chance for
failure was 0.13. Factors present at the start of the period (age,
CS) may increase F to 0.29 and 0.60, respectively, when they
are the highest-risk class. The CHD-treatment-related predic-
tors (KTIV0 and MAP) increase basal risk to 0.32 for a low
dose, and to 0.49 for MAP over 115 mm Hg. Table 10 shows the
Fig. 1. F values according to significant risk factors in chronic hemo-
dialysis. Symbol () is the risk of MAP > 115 mm Hg or KT/V0 s
0.90.
Table 10. Probability of failure according to number of significant
factors in high risk class
Number of
factors in
high risk class
Estimated
probability
of failure
Number of
patients
Observed
number of
failures (death)
0 0.13 21 3 (0)
1 0.29—0.60 49 17 (3)
2 0.57—0.91 26 18 (3)
3 or4 0.90—0.99 8 8(1)
probability of failure according to the number of factors in the
highest-risk class. The last column expresses the number of
failures associated with each group. The seven patients who
died had one or more variables in the highest-risk class.
Discussion
The aim of CHD treatment is to prolong the patient's life, to
reduce complications to a minimum, and to allow a normal life.
This last aspect is not easy to evaluate objectively, Most
authors use mortality or morbidity as criteria to assess treat-
ment results [2, 3, 5, 17, 18J.
In this study, treatment failures were death or admission to
hospital. Therefore, classification is objective and its results can
be compared to those of other epidemiological studies. Treat-
ment for chronic renal failure (CRF) has been established in
Uruguay since 1980, by law No. 14897, stating the obligation of
providing unrestricted care to all patients with end-stage CRF.
The National Fund Resource provides financing for hemodial-
ysis, continuous ambulatory peritoneal dialysis and renal trans-
plantation. In January 1987, 511 patients were on hemodialysis
(170 per million population) and in June 1990 there were 950
(316 patients per million population).
Most morbidity and mortality studies consider only the
effects of demographic characteristics or factors present at the
start of treatment (for example, associated disorders, compli-
cations, and severity of uremia at start of therapy) [2, 3, 17],
even after several years of CHD treatment.
The National Cooperative Dialysis Study (NCDS) [5] is the
most important report on the influence of the quality of dialysis
on the patients' prognosis. Our results confirm the prognostic
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importance of the patient's age and cardiac diseases, as well as
CHD treatment-related factors followed during the observation
period. Hypertension history is a well established factor for
cardiovascular MM both in the hemodialyzed [1, 19, 201 and in
the general population [21]. In this study, HH was significant
when analyzed separately; it did not appear as a predictor in the
simultaneous study. We believe that CS summarizes correctly
the hypertensive past, and whenever there are well-defined
cardiac disorders, hypertension history does not add any new
data for statistical simultaneous analysis.
MAP also has a significant weight on the simultaneous study
and it was the second most important relative prognostic
predictor. This variable differs from HH, since hypertension
during the interval could modify the pre-existing cardiac status.
Thereafter, MAP becomes a new risk factor that does not
depend on the cardiac assessment at the beginning of the
observation period. These results coincide with those obtained
by Degoulet et al [1] and Lundin et al [22].
Like the NCDS, we have observed that efficiency of hemo-
dialysis treatment during the observation period is associated
with prognosis. As indicated previously, in the participating
units, the dose of dialysis was considered acceptable when
KT/V0 > 0.80. As seen from this study and according to Gotch
[23], our target value of KT/V01 should be higher. Three
patients did not reach the adequate average dialysis dose
according to the initial criteria (KT/V0 > 0.80) and 27 accord-
ing to the criteria arising from our results. The average weight
of these 27 patients was 74.2 13.3 kg and the average weight
of the remaining 77 was 61.3 11.4 kg (P < 0.05). This
difference probably explains why these patients showed a
KT/V0 lower than that of the rest of the population. The
question is if other factors associated to morbidity and mortality
may have been responsible for the low doses. KT/V0 main-
tained its predictive value when analyzed together with the
other factors usually associated with MM. We therefore believe
that KT/V0 has an independent predictive value, without
pretending to attribute any causality to it.
When replacing KTIVO for PCR and BUN (that have been
considered analogous to KTIVOC in NCDS's reanalysis) the
latter variables were not significant. The strong connection
verified in NCDS's reanalysis [23] between these three varia-
bles was in relation with NCDS experimental design: patients
were included in four experimental groups, and remained with
BUN stable values during the study, thanks to permanent
adjustment of KT/V0 according to PCR. In our study, how-
ever, the range tolerated for BUN and PCR was much wider.
The fact that two treatment-related variables (MAP and
KTfV01) were significant in this analysis reveals that, within the
considered range, both have an independent prognostic value,
and that the quality of treatment is not completely defined by
any one of them. In fact, KTIV0 is an index of low molecular
clearance, but it does not consider the patient's volume control,
which is the most important pathogenic hypertension factor in
CRF [24]. Moreover, it is well known that a certain percentage
of CHD patients [1, 24] require antihypertensive drugs in spite
of an adequate volume control. Therefore, the MAP predictor
defines, under the conditions of this study, one aspect of the
CHD treatment disregarded by KT/V01.
As we can see in Table 10, the predictors selected for our
analysis satisfactorily explain the patient's evolution through-
out the observation period. Therefore, the possibility of failure
associated with those predictors may be used as a risk index.
Although establishing a correlation with predictive power
does not prove that there is a cause and effect relation, from the
hemodialysis practitioner's points of view, the results of this
study provide practical guidelines. With efficient hypertension
control and hemodialysis procedure, two important MM risk
factors in CHD patients can be overcome.
Our results differ from previous observations about the
importance of socio-economic and psychological status [4]. We
were particularly surprised to find that indigence or poverty in
57 of our patients was not associated with a higher number of
failures. Perhaps we should define the result of treatment in
another way, considering also rehabilitation, to properly assess
the importance of these variables.
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